Skip to main content
All lobbying clients

AMERICANS FOR HOMEOPATHY CHOICE ACTION

Lobbying client · District of Columbia · filed 2025 to 2026

Organization supporting the rights of Americans who use homeopathy

$420,000 Reported spend
14 Filings counted
1 Outside firm hired
2 Bills named

Spend is reported income plus in-house expenses across 14 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 2 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 2

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 2
  • H.R. 7050
    Homeopathic Drug Product Safety, Quality, and Transparency Act
    3 filings
  • S. 4692
    Homeopathic Drug Product Safety, Quality, and Transparency Act
    2 filings
 Reported by year 2 years
  • 2026 $180,000 6 filings
  • 2025 $240,000 8 filings
 Issues lobbied 1

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 5
  • HOUSE OF REPRESENTATIVES 14
  • SENATE 14
  • Food & Drug Administration (FDA) 6
  • Centers For Disease Control & Prevention (CDC) 1
  • Health & Human Services, Dept of (HHS) 1
 Recent filings 14 total
Q3 report
VENABLE LLP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 15, 2026
View → Q3 report
AMERICANS FOR HOMEOPATHY CHOICE ACTION
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 expenses · posted Oct 10, 2026
View → Q2 report
AMERICANS FOR HOMEOPATHY CHOICE ACTION
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 expenses · posted Jul 17, 2026
View → Q2 report
VENABLE LLP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 17, 2026
View → Q1 report
AMERICANS FOR HOMEOPATHY CHOICE ACTION
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $10,000 expenses · posted Apr 20, 2026
View → Q1 report
VENABLE LLP
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 15, 2026
View → Q4 report
AMERICANS FOR HOMEOPATHY CHOICE ACTION
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $10,000 expenses · posted Jan 20, 2026
View → Q4 report
VENABLE LLP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $50,000 income · posted Jan 13, 2026
View → Q3 report
AMERICANS FOR HOMEOPATHY CHOICE ACTION
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $10,000 expenses · posted Oct 16, 2025
View → Q3 report
VENABLE LLP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 16, 2025
View → Q2 report
AMERICANS FOR HOMEOPATHY CHOICE ACTION
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $10,000 expenses · posted Jul 18, 2025
View → Q2 report
VENABLE LLP
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 15, 2025
View → Q1 report
VENABLE LLP
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 14, 2025
View → Q1 report
AMERICANS FOR HOMEOPATHY CHOICE ACTION
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $10,000 expenses · posted Apr 10, 2025
View →

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem